17.01.2018 22:02:00

Faruqi & Faruqi, LLP is Investigating United Therapeutics Corporation (UTHR) on Behalf of its Shareholders

NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ: UTHR).

Faruqi & Faruqi, LLP. (PRNewsfoto/Faruqi & Faruqi, LLP)

The investigation focuses on whether the Company and/or its directors and officers breached their fiduciary duties.

Request more information now by clicking herewww.faruqilaw.com/UTHR.  There is no cost or obligation to you.

Take Action

If you currently own United Therapeutics stock and would like to discuss your legal rights, please visit www.faruqilaw.com/UTHR.  You can also contact us by calling Nina Varindani, Esq. either via e-mail at nvarindani@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330 or Michael Van Gorder, Esq. at mvangorder@faruqilaw.com.

Faruqi & Faruqi, LLP also encourages anyone with information regarding the Company's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

Nina Varindani, Esq.
Michael Van Gorder, Esq.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor 
New York, NY 10017
Telephone: (877) 247-4292 or (212) 983-9330
nvarindani@faruqilaw.com 
mvangorder@faruqilaw.com

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/faruqi--faruqi-llp-is-investigating-united-therapeutics-corporation-uthr-on-behalf-of-its-shareholders-300584197.html

SOURCE Faruqi & Faruqi, LLP

Analysen zu United Therapeutics Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

United Therapeutics Corp. 343,40 0,50% United Therapeutics Corp.